The evaluation of clinical eficacy of 17β-estradiol vaginal tablets in the atropic vaginitis therapy

Edyta Wlaźlak; Grzegorz Surkont; Jacek Suzin

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

5/2004
vol. 3

Send email

Copy url:

abstract:

The evaluation of clinical eficacy of 17β-estradiol vaginal tablets in the atropic vaginitis therapy

Edyta Wlaźlak

,

Grzegorz Surkont

,

Jacek Suzin

Prz Menopauz 2004; 5: 24-31

Online publish date: 2004/10/22

View full text Get citation

In the study 245 women with urogynecologic complaints and estrogen deficiency took part. There was evaluated the eficiency and tolerance of therapy. Conclusions. 1. Vaginal therapy with 25 µg 17β-estradiol tablets is efficient in treatment of atrophic vaginitis and dyspareunia in postmenopausal women. 2. Vaginal therapy with 25 µg 17β-estradiol tablets gives improvement in urinary incontinence complaints in women with estrogen deficiency. 3. Therapy is well tolerated by patients. 4. Vaginal therapy with estradiol tablets in aplicator is noticed by most of the patients as more comfortable than other ways of aplications.

keywords:

The evaluation of clinical eficacy of 17β-estradiol vaginal tablets in the atropic vaginitis therapy

Edyta Wlaźlak , Grzegorz Surkont , Jacek Suzin

vaginal estrogen therapy, atrophic vaginitis, dyspareunia, urinary incontinence, menopause

Edyta Wlaźlak

,

Grzegorz Surkont

,

Jacek Suzin